Bath & Body Works, Inc. (NYSE:BBWI) Stock Has Average Target Price of $22.13 According to Brokerages

Shares of Bath & Body Works, Inc. (NYSE:BBWI – Get Free Report) have been given an average rating of “Hold” by the twenty ratings firms that are presently covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, fifteen have issued a hold recommendation and four have issued a buy recommendation on the company. The average 12-month price objective among brokers that have updated their coverage on the stock in the last year is $22.13.

A number of brokerages recently commented on BBWI. Citigroup upgraded Bath & Body Works from a “neutral” rating to a “buy” rating and set a $25.00 target price for the company in a report on Tuesday, August 18th. Weiss Ratings raised shares of Bath & Body Works from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday, July 9th. Wells Fargo & Company decreased their price objective on shares of Bath & Body Works from $26.00 to $24.00 and set an “overweight” rating for the company in a report on Thursday, August 27th. Jefferies Financial Group raised their target price on shares of Bath & Body Works from $22.00 to $23.00 and gave the stock a “hold” rating in a research report on Tuesday, July 28th. Finally, UBS Group cut their target price on shares of Bath & Body Works from $19.00 to $17.00 and set a “neutral” rating on the stock in a research note on Thursday, August 27th.

Check Out Our Latest Stock Report on Bath & Body Works

Hedge Funds Weigh In On Bath & Body Works

A number of institutional investors have recently added to or reduced their stakes in the company. BlackRock Inc. bought a new stake in shares of Bath & Body Works during the 2nd quarter valued at $449,065,000. Geode Capital Management LLC lifted its position in Bath & Body Works by 2.9% during the 4th quarter. Geode Capital Management LLC now owns 3,960,475 shares of the company’s stock valued at $79,542,000 after acquiring an additional 110,602 shares during the period. Vaughan Nelson Investment Management L.P. lifted its position in Bath & Body Works by 33.8% during the 1st quarter. Vaughan Nelson Investment Management L.P. now owns 2,852,040 shares of the company’s stock valued at $53,248,000 after acquiring an additional 719,795 shares during the period. Arrowstreet Capital Limited Partnership boosted its stake in Bath & Body Works by 34.2% during the first quarter. Arrowstreet Capital Limited Partnership now owns 2,777,576 shares of the company’s stock worth $51,857,000 after acquiring an additional 707,449 shares in the last quarter. Finally, Norges Bank bought a new stake in Bath & Body Works during the fourth quarter worth about $55,504,000. Institutional investors own 95.14% of the company’s stock.

Bath & Body Works Stock Up 3.0%

Shares of Bath & Body Works stock opened at $17.98 on Wednesday. The company’s fifty day simple moving average is $18.44 and its two-hundred day simple moving average is $19.06. Bath & Body Works has a 12-month low of $14.27 and a 12-month high of $27.40. The firm has a market cap of $3.63 billion, a PE ratio of 4.68, a price-to-earnings-growth ratio of 0.88 and a beta of 1.40.

Bath & Body Works (NYSE:BBWI – Get Free Report) last posted its earnings results on Wednesday, August 26th. The company reported $0.62 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.24 by $0.38. Bath & Body Works had a negative return on equity of 53.48% and a net margin of 10.83%.The company had revenue of $1.51 billion for the quarter, compared to analysts’ expectations of $1.50 billion. During the same period last year, the firm earned $0.30 earnings per share. Bath & Body Works’s quarterly revenue was down 2.3% on a year-over-year basis. Bath & Body Works has set its Q3 2026 guidance at 0.070-0.120 EPS and its FY 2026 guidance at 2.600-2.800 EPS. As a group, sell-side analysts expect that Bath & Body Works will post 2.73 earnings per share for the current fiscal year.

Bath & Body Works Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, September 4th. Shareholders of record on Friday, August 21st were issued a $0.20 dividend. The ex-dividend date was Friday, August 21st. This represents a $0.80 annualized dividend and a yield of 4.5%. Bath & Body Works’s dividend payout ratio (DPR) is 20.83%.

Bath & Body Works Company Profile

(Get Free Report)

Bath & Body Works, Inc is a specialty retailer focused on personal care and home fragrance products. Its portfolio includes body lotions and creams, shower products, fragrances, hand soaps and sanitizers, three-wick candles, wall-plug air fresheners, and other home-fragrance items. The company markets products under the Bath & Body Works brand and regularly introduces seasonal and limited-edition collections.

The company sells its products through a network of company-operated stores, its e-commerce website, and other direct channels.

Further Reading

Analyst Recommendations for Bath & Body Works (NYSE:BBWI)

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.